The report will be delivered in 2-3 business days.

TNF Alpha Inhibitors Global Market Report 2020-30: COVID-19 Growth And Change

Tnf Alpha Inhibitors
Purchase Options
Request Sample
Request For Discount
FAQ

Starting Price : $ 4000.00 $3200.00 | Pages : 150 | Published : October 2020 | SKU CODE : 7724 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The TNF alpha inhibitors market consists of sales of tumor necrosis factor-alpha (TNF-a) inhibitors by entities that manufacture TNF alpha inhibitors. TNF alpha inhibitors are a group of medicines that conquer the body’s natural response to TNF, a protein produced by white blood cells, involved in early inflammatory events. These are important treatments in the number of inflammatory conditions including spondylarthritis, psoriasis, rheumatoid arthritis (RA), and inflammatory bowel disease (IBD).

The global TNF alpha inhibitors market is expected to decline from $40.66 billion in 2019 to $39.01 billion in 2020 at a compound annual growth rate (CAGR) of -4.06%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $42.86 billion in 2023 at a CAGR of 3.18%.

North America was the largest region in the TNF alpha inhibitors market in 2019. Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The growing prevalence of inflammatory diseases such as inflammatory bowel disease and psoriasis is a key factor driving the growth of the TNF alpha inhibitors market. Tumor necrosis factor-alpha (TNF alpha) inhibitors are commonly used in gastroenterology, dermatology and rheumatology for the treatment of various immune-mediated inflammatory diseases. Globally, the prevalence of inflammatory bowel disease (IBD) is about 0.5-24.5 cases for ulcerative colitis per 100,000 person-years and 0.1-16 cases for Crohn`s disease per 100,000 person-years, and overall, IBD prevalence is 396 cases per 100,000 people each year. Thus, the increasing number of cases of inflammatory diseases increases the demand for TNF alpha inhibitors contributing to the growth of the market.

The adverse side effects of TNF alpha inhibitors on patients are expected to limit the growth of the TNF alpha inhibitors market. The multiple adverse effects of TNF alpha inhibition identified by clinical trials and post-marketing surveillance include injection site reactions, neutropenia, infusion reactions, and infections. According to the U.S. Food and Drug Administration (FDA), TNA alpha inhibitors can cause serious infections in people with weaker immune systems or low resistance levels. The infections can be bacterial, mycobacterial, fungal, and viral leading to various diseases such as tuberculosis, histoplasmosis, candidiasis, blastomycosis, and hepatitis B. These side effects force patients to prefer alternatives such as non-TNF biologics, which hampers the growth of the market.

In May 2020, AbbVie Inc, a US-based biopharmaceutical company, completed the acquisition of Allergan plc for an amount of $63 billion. The acquisition is expected to expand and diversify AbbVie Inc’s revenue base and its existing immunology portfolio. Allergan plc is an Ireland-based pharmaceutical company engaged in manufacturing and marketing drugs and medical devices in the areas of the central nervous system, eye care, medical aesthetics, and gastroenterology.

The major players covered in the global tnf alpha inhibitors market are AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A, Novartis International AG, Pfizer Inc., Merck & co. Inc., Janssen Biotech, Ablynx, Momenta Pharmaceuticals, Celgene Corporation, GlaxoSmithKline, Sanofi-Aventis, Zydus Cadila, HanAll Biopharma, AryoGen Biopharma, LG Life Sciences, Samsung Bioepis, Bionovis, Celltrion Healthcare, CASI Pharmaceuticals, EPIRUS Biopharmaceuticals , HanAll Biopharma, Intas Pharmaceuticals, LEO Pharma, MedImmune, Momenta Pharmaceuticals, Reliance Life Sciences, Sandoz, Biogen, AstraZeneca.

The countries covered in the global tnf alpha inhibitors market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The regions covered in the global tnf alpha inhibitors market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global tnf alpha inhibitors market is segmented - 1) By Drug: Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), Simponi (golimumab). 2) By Route of Administration: Oral, Subcutaneous, Intravenous, Others. 3) By Disease Type: Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis, Others.

    1. Executive Summary

    2. TNF Alpha Inhibitors Market Characteristics

    3. TNF Alpha Inhibitors Market Size And Growth

    3.1. Global TNF Alpha Inhibitors Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global TNF Alpha Inhibitors Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. TNF Alpha Inhibitors Market Segmentation

    4.1. Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Remicade (infliximab)

    Enbrel (etanercept)

    Humira (adalimumab)

    Cimzia (certolizumab pegol)

    Simponi (golimumab

    4.2. Global TNF Alpha Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Oral

    Subcutaneous

    Intravenous

    Others

    4.3. Global TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Inflammatory Bowel Disease

    Psoriatic Arthritis

    Ulcerative Colitis (UC)

    Rheumatoid Arthritis

    Ankylosing Spondylitis

    Others

    5. TNF Alpha Inhibitors Market Regional And Country Analysis

    5.1. Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific TNF Alpha Inhibitors Market

    6.1. Asia-Pacific TNF Alpha Inhibitors Market Overview

    6.2. Asia-Pacific TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China TNF Alpha Inhibitors Market

    7.1. China TNF Alpha Inhibitors Market Overview

    7.2. China TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.3. China TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India TNF Alpha Inhibitors Market

    8.1. India TNF Alpha Inhibitors Market Overview

    8.2. India TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan TNF Alpha Inhibitors Market

    9.1. Japan TNF Alpha Inhibitors Market Overview

    9.2. Japan TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia TNF Alpha Inhibitors Market

    10.1. Australia TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia TNF Alpha Inhibitors Market

    11.1. Indonesia TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea TNF Alpha Inhibitors Market

    12.1. South Korea TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe TNF Alpha Inhibitors Market

    13.1. Western Europe TNF Alpha Inhibitors Market Overview

    13.2. Western Europe TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK TNF Alpha Inhibitors Market

    14.1. UK TNF Alpha Inhibitors Market Overview

    14.2. UK TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany TNF Alpha Inhibitors Market

    15.1. Germany TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France TNF Alpha Inhibitors Market

    16.4. France TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.5. France TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe TNF Alpha Inhibitors Market

    17.1. Eastern Europe TNF Alpha Inhibitors Market Overview

    17.2. Eastern Europe TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia TNF Alpha Inhibitors Market

    18.1. Russia TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America TNF Alpha Inhibitors Market

    19.1. North America TNF Alpha Inhibitors Market Overview

    19.2. North America TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA TNF Alpha Inhibitors Market

    20.1. USA TNF Alpha Inhibitors Market Overview

    20.2. USA TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America TNF Alpha Inhibitors Market

    21.1. South America TNF Alpha Inhibitors Market Overview

    21.2. South America TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil TNF Alpha Inhibitors Market

    22.1. Brazil TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East TNF Alpha Inhibitors Market

    23.1. Middle East TNF Alpha Inhibitors Market Overview

    23.2. Middle East TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa TNF Alpha Inhibitors Market

    24.1. Africa TNF Alpha Inhibitors Market Overview

    24.2. Africa TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. TNF Alpha Inhibitors Market Competitive Landscape And Company Profiles

    25.1. TNF Alpha Inhibitors Market Competitive Landscape

    25.2. TNF Alpha Inhibitors Market Company Profiles

    25.2.1. AbbVie Inc.

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Amgen Inc.

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Johnson & Johnson Services, Inc.

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. UCB S.A

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Novartis International AG

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The TNF Alpha Inhibitors Market

    27. TNF Alpha Inhibitors Market Trends And Strategies

    28. TNF Alpha Inhibitors Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global TNF Alpha Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: China, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: China, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: India, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: India, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Japan, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Japan, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Australia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Australia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: UK, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: UK, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Germany, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: Germany, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: France, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: France, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: Russia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: Russia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: North America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: North America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: USA, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: USA, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: South America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: South America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Africa, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: Africa, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 46: AbbVie Inc. Financial Performance
  • Table 47: Amgen Inc. Financial Performance
  • Table 48: Johnson & Johnson Services, Inc. Financial Performance
  • Table 49: UCB S.A Financial Performance
  • Table 50: Novartis International AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global TNF Alpha Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: China, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: China, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: India, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: India, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: UK, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: UK, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: France, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: France, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: North America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: North America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: USA, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: USA, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: South America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: South America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 46: AbbVie Inc. Financial Performance
  • Figure 47: Amgen Inc. Financial Performance
  • Figure 48: Johnson & Johnson Services, Inc. Financial Performance
  • Figure 49: UCB S.A Financial Performance
  • Figure 50: Novartis International AG Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Read More
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Read More
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Read More
Innovations In The Diabetes Therapies Market
Read More
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Read More
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
Read More
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Read More
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Read More
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)